E112 692
[2]
Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic out- comes of kidney-sparing surgery versus radical nephroureterec- tomy for upper tract urothelial carcinoma: a systematic review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052–68.[3]
Roupreˆt M, Babjuk M, Compe´rat E, et al. European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 2015;68:868–79.[4]
Ishikawa S, Abe T, Shinohara N, et al. Impact of diagnostic uretero- scopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 2010;184: 883–7.[5]
Villa L, Cloutier J, Letendre J, et al. Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 2016;34:1201–6.Thomas Seisen
a,
*
Marko Babjuk
b
Morgan Roupreˆt
a
a
Academic Department of Urology, Pitie´-Salpe´trie`re Hospital,
Assistance-Publique Hoˆpitaux de Paris, Pierre et Marie Curie Medical School,
University Paris 6, Paris, France
b
Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles
University, Praha, Czech Republic
*Corresponding author. Department of Urology, Pitie´-Salpe´trie`re
Hospital, 47-83 Boulevard de l’Hoˆpital, 75013 Paris, France.
E-mail address:
thomas.seisen@gmail.com(T. Seisen).
September 13, 2016
E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) e 1 1 1 – e 1 1 2
e112